Log In
Print this Print this

Vaprisol, conivaptan

Also known as: YM087

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionDual vasopressin 1a (V1a) receptor and V2 receptor antagonist
Molecular Target Vasopressin 1a (V1a) receptor ; Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 1 (V1) receptor antagonist; Vasopressin 2 (V2) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyponatremia
Indication DetailsTreat euvolemic hyponatremia; Treat hypervolemic hyponatremia; Treat hyponatremia
Regulatory Designation
PartnerCumberland Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today